- Price
- 1.25
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Currency
- GBX
Delayed data · Source: Aquis Stock Exchange
| 13 Jul 2026 | 07:00:10 | Corporate Update & Board Changes |
| 12 Jun 2026 | 16:30:00 | Holding(s) in Company |
| 4 Jun 2026 | 07:00:04 | Corporate Update |
| 31 Mar 2026 | 07:00:13 | Commercial Update |
| 11 Dec 2025 | 07:20:16 | Half-year Report |
Incanthera plc is a company focused on technologies in dermatology and oncology. It identifies and develops therapeutic and cosmetic applications utilizing targeted delivery technologies. The company operates a luxury skincare brand, Skin+CELL, which offers products such as face, body, and hand creams, face serum, and eye cream, sold directly to consumers through its website. Incanthera aims to address unmet needs in skin health and cellular protection, with plans to expand its product range to include additional bioactive ingredients and SPF formulations.
| 13 Jul 2026 | 07:00:10 | Corporate Update & Board Changes |
| 12 Jun 2026 | 16:30:00 | Holding(s) in Company |
| 4 Jun 2026 | 07:00:04 | Corporate Update |
| 31 Mar 2026 | 07:00:13 | Commercial Update |
| 11 Dec 2025 | 07:20:16 | Half-year Report |
Incanthera plc is a company focused on technologies in dermatology and oncology. It identifies and develops therapeutic and cosmetic applications utilizing targeted delivery technologies. The company operates a luxury skincare brand, Skin+CELL, which offers products such as face, body, and hand creams, face serum, and eye cream, sold directly to consumers through its website. Incanthera aims to address unmet needs in skin health and cellular protection, with plans to expand its product range to include additional bioactive ingredients and SPF formulations.